Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis
Author:
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference19 articles.
1. How to determine the cost-effectiveness of available allergic rhinitis treatments;Blaiss;Drug Benefit Trends,1998
2. The prevalence of allergic skin test reactivity to eight common aeroallergens in the US population: results from the second National Health and Nutrition Examination Survey;Gergen;J Allergy Clin Immunol,1987
3. The costs of allergic rhinitis;Ross;Am J Man Care,1996
4. Improving the value of care for allergic rhinitis;Stempel;Drug Benefit Trends,1996
5. Efficacy and tolerability comparison of ebastine 10 and 20mg with loratadine 10mg: a double-blind, randomised study in patients with perennial allergic rhinitis;Davies;Clin Drug Invest,1998
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ebastine in the Treatment of Allergic Rhinitis and Urticaria: 30 Years of Clinical Studies and Real-World Experience;Journal of Investigational Allergology and Clinical Immunology;2020-06-18
2. The second-generation antihistamines in the complex treatment of allergic rhinitis;Medical Council;2019-04-28
3. Extracellular Signal-Regulated Kinase Mediates Ebastine-Induced Human Follicle Dermal Papilla Cell Proliferation;BioMed Research International;2019-02-11
4. Onset of action for loratadine tablets for the symptomatic control of seasonal allergic rhinitis in adults challenged with ragweed pollen in the Environmental Exposure Unit: a post hoc analysis of total symptom score;Allergy, Asthma & Clinical Immunology;2018-01-16
5. EBASTINE. A REASONABLE CHOICE;Russian Journal of Allergy;2017-12-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3